Silence Therapeutics Plc - Sales Analysis Snapshot

Business Description
This Report provides a comprehensive Sales & Margin summary analysis for Silence Therapeutics Plc Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.

Silence Therapeutics Plc. The Group's principal activity is researching and developing pharmaceutical products. It focuses on Ribonucleic Acid Interference technology, as it can selectively silence genes linked to the onset of disease, thus leading to the creation of a new class of therapeutic products. The Group is developing two products relating to Age-Related Macular Degeneration and Acute Kidney Injury. The Group operates in the United Kingdom.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report